No government entities are investigating Biogenesis

13 Comments

While the additional Braun document is the sexy takeaway from Quinn and Fish’s report at ESPN.com, this has greater significance:

Sources familiar with MLB’s investigation said officials have tried to spark an investigation by the U.S. Drug Enforcement Administration. So far, the DEA and FBI have not initiated investigations, several sources told “Outside the Lines.” Nor have state authorities hinted at an interest, with a Florida Department of Law Enforcement saying, “FDLE is not investigating Biogenesis of America, and we have not received any complaints.”

It can look as bad as possible for the players named in the report. But without anyone with subpoena power investigating this, Major League Baseball has nowhere to go to get any additional information about this stuff, let alone enough to serve as the basis for discipline of the named players.

Padres may have more interest in Dallas Keuchel than Bryce Harper

Dallas Keuchel
Getty Images
1 Comment

An interesting tidbit today from The Athletic’s Ken Rosenthal, who noted that ongoing talks between agent Scott Boras and the Padres have focused more on starting pitcher Dallas Keuchel than slugger Bryce Harper. Earlier this week, there were conflicting reports on the Padres’ level of interest in Harper — MLB Network’s Jon Heyman heard the club had not ruled out another big signing after getting Manny Machado, while Kevin Acee of the San Diego Union-Tribune talked to multiple sources who believed otherwise — but any agreement between the two is looking unlikelier by the day.

As for Keuchel, Rosenthal cautions that a potential deal is still a “longshot,” especially as the team has other, cheaper options in mind. The 31-year-old southpaw turned down a qualifying offer from the Astros last year and is likely angling for something north of the five-year, $90 million contract extension he rejected from the club in 2016. He’s coming off of another solid performance in Houston, where he went 12-11 in 34 starts with a 3.74 ERA, 2.6 BB/9, 6.7 SO/9, and 3.6 fWAR through 204 2/3 innings in 2018.

While Keuchel has failed to garner substantial interest around the league this offseason, Heyman points out that the Phillies are looking to establish themselves as frontrunners for the lefty — and they’re far less likely to have hang-ups about his asking price, too.